Pharmacology, Toxicology and Pharmaceutical Science
Untranslated RNA
100%
Heart Arrest
89%
microRNA
84%
Cardiovascular Disease
78%
Diseases
59%
Biological Marker
48%
Heart Disease
37%
Long Untranslated RNA
27%
Coronavirinae
18%
Transcriptome
18%
Parkinson's Disease
18%
microRNA 1
18%
6 N Methyladenosine
18%
Neuron Specific Enolase
18%
Pathophysiology
13%
Messenger RNA
13%
Heart Injury
12%
Disease Exacerbation
11%
Neurologic Disease
10%
Circulating microRNA
9%
Congestive Heart Failure
9%
Infection
7%
SARS Coronavirus
7%
RNA-Sequencing
6%
Small Untranslated RNA
6%
Adenosine Triphosphate
6%
Disease Course
6%
microRNA 21
6%
Clinical Study
6%
Comorbidity
6%
Medicine and Dentistry
Untranslated RNA
75%
Cardiovascular Disease
66%
Diseases
39%
Heart Arrest
37%
Biological Marker
27%
Heart Disease
18%
microRNA
18%
Cardiovascular System
18%
Coronavirinae
18%
microRNA 1
18%
Heart Protection
18%
Sex Difference
18%
Heart Injury
12%
Neurologic Disease
10%
Clinical Study
10%
Odds Ratio
9%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Infection
7%
Resuscitation
7%
Cardiovascular System
7%
Disease Exacerbation
6%
Disease Course
6%
Public Health
6%
Congestive Heart Failure
6%
Comorbidity
6%
Keyphrases
Heart Disease
18%
MicroRNA-21 (miR-21)
18%
MicroRNA-1 (miR-1)
18%
Interdisciplinary Communication
18%
MiR-574-5p
18%
N6-methyladenosine
18%
RNA Regulatory Network
18%
MicroRNA
18%
Sex Differences
18%
Cardiac Arrest
18%
Neurological Outcome
18%
RNA in Disease
18%
Brain-heart Axis
18%
TRIM8
13%
International Journals
9%
Transdisciplinary Collaboration
9%
Future Pandemics
9%
Cardiovascular Pathophysiology
9%
Prenatal Development
9%
M6A RNA Methylation
9%
Postnatal Development
9%
Internal Modification
9%
High-throughput
9%
Single-cell Analysis
9%
COST Action
9%
Heart Failure Patients
9%
Molecular Science
9%
Neurological Injury
7%
Improving Health Care
7%
Financial Burden
7%
Modernity
6%
Patient Benefit
6%
Therapeutic Biomarkers
6%
Mitochondrial microRNAs
6%
Mitochondrial Metabolism
6%
Outcome Prognosis
5%